Our result is encouragingly inconsistent with recent findings that point to the fact that a reduced expression of KLF9 is linked to poor survival and prognosis in pancreatic ductal adenocarcinoma and leads to tumor metastasis (9). This evidence concerns the gene KLF9 and pancreatic ductal adenocarcinoma.